Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis

Susanne Gaertner, Katrien L. de Graaf, Bernhard Greve, Robert Weissert

Neurology · 2004 · 68 citations · 9 references

Concepts

Abstract

Antibodies against native glycosylated myelin-oligodendrocyte-glycoprotein (MOG) were measured by ELISA in patients with multiple sclerosis (MS) and controls. Anti-MOG IgM antibodies were elevated during the first demyelinating event. Higher MOG-specific IgG antibodies were found in patients during relapses and in secondary chronic progressive MS compared to patients in remission and healthy controls. Antibodies against native MOG may be a potential biomarker for MS.

References

9